t: 01582 726661
e: secretariat@scs.org.uk
Jiangsu Trautec Medical Technology
Categories
Telephone: +05198 2885 966
Email: info@trautec.com.cn
Company Profile
Jiangsu Trautec Medical Technology (Trautec), founded in 2015, is dedicated with a mission of researching and developing recombinant collagen (SRHC) biomaterials. Till now, about 100-200 brands have partnered with Trautec, including more than 30 listed companies.
Trautec has over 17 million dollars invested in research and development (R&D) of synthetic recombinant human collagen (SRHC®) production based on biomaterials. The 100,000 square feet production facility is based in Jiangsu, and its U.S. branch headquartered in Ontario, California. The company will continue to expand the application of SRHC® products in high-end fields such as medicine, medical, regeneration and medical aesthetics, and occupy the forefront of the industry, aiming to build a global leading company in recombinant collagen products and recreating the existing substances by synthetic technology (CDMO).
« Back
